HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer

GSR Raju, E Pavitra, SS Bandaru, GL Varaprasad… - Molecular cancer, 2023 - Springer
HOX transcript antisense intergenic RNA (HOTAIR) is an oncogenic non-coding RNA whose
expression is strongly correlated with the tumor grade and prognosis of a variety of …

Biological mechanisms to reduce radioresistance and increase the efficacy of radiotherapy: state of the art

F Busato, BE Khouzai, M Mognato - International journal of molecular …, 2022 - mdpi.com
Cancer treatment with ionizing radiation (IR) is a well-established and effective clinical
method to fight different types of tumors and is a palliative treatment to cure metastatic …

Targeting the DNA damage response for cancer therapy by inhibiting the kinase Wee1

AB Bukhari, GK Chan, AM Gamper - Frontiers in Oncology, 2022 - frontiersin.org
Cancer cells typically heavily rely on the G2/M checkpoint to survive endogenous and
exogenous DNA damage, such as genotoxic stress due to genome instability or radiation …

Extracellular vesicles-associated miRNAs in triple-negative breast cancer: From tumor biology to clinical relevance

FCB Berti, MV Tofolo, E Nunes-Souza, R Marchi… - Life sciences, 2024 - Elsevier
Breast cancer (BC), a heterogeneous group of diseases, is the most frequent type and the
leading cause of cancer-related death among women worldwide. Tumor heterogeneity …

Subclinical dose irradiation triggers human breast cancer migration via mitochondrial reactive oxygen species

JD Rondeau, JA Van de Velde, Y Bouidida… - Cancer & …, 2024 - Springer
Background Despite technological advances in radiotherapy, cancer cells at the tumor
margin and in diffusive infiltrates can receive subcytotoxic doses of photons. Even if only a …

Recent clinical advances on long non-coding RNAs in triple-negative breast cancer

DD Singh, HJ Lee, DK Yadav - Cells, 2023 - mdpi.com
Triple-negative breast cancer (TNBC) is a more aggressive type of breast cancer due to its
heterogeneity and complex molecular mechanisms. TNBC has a high risk for metastasis …

LINC00963-FOSB-mediated transcription activation of UBE3C enhances radioresistance of breast cancer cells by inducing ubiquitination-dependent protein …

Y Wang, M Liu, X Liu, X Guo - Journal of Translational Medicine, 2023 - Springer
Background The ubiquitin protein ligase E3C (UBE3C) has been reported to play an
oncogenic role in breast cancer (BRCA). This work further investigates the effect of UBE3C …

[PDF][PDF] Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials.

K Mehta, M Hegde, S Girisa, R Vishwa… - Military Medical …, 2024 - Springer
The extensive heterogeneity and the limited availability of effective targeted therapies
contribute to the challenging prognosis and restricted survival observed in triple-negative …

[PDF][PDF] Innovative therapeutic strategies to overcome radioresistance in breast cancer

CR Arnold, J Mangesius, I Portnaia… - Frontiers in …, 2024 - frontiersin.org
Enhanced understanding of the molecular basis of radioresistance paves the way for novel
therapeutic interventions, potentially translatable into clinical applications. This section …

Effects of noncoding RNAs in radiotherapy response in breast cancer: a systematic review

T Oghabi Bakhshaiesh, R Esmaeili - Cell Cycle, 2022 - Taylor & Francis
Radiotherapy has an essential role in breast cancer treatment. However, tumor cells may be
resistant to radiotherapy. Noncoding RNAs are considered regulators of different pathways …